Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 29

1.

A Genome-wide Association Study Identifies Risk Alleles in Plasminogen and P4HA2 Associated with Giant Cell Arteritis.

Carmona FD, Vaglio A, Mackie SL, Hernández-Rodríguez J, Monach PA, Castañeda S, Solans R, Morado IC, Narváez J, Ramentol-Sintas M, Pease CT, Dasgupta B, Watts R, Khalidi N, Langford CA, Ytterberg S, Boiardi L, Beretta L, Govoni M, Emmi G, Bonatti F, Cimmino MA, Witte T, Neumann T, Holle J, Schönau V, Sailler L, Papo T, Haroche J, Mahr A, Mouthon L, Molberg Ø, Diamantopoulos AP, Voskuyl A, Brouwer E, Daikeler T, Berger CT, Molloy ES, O'Neill L, Blockmans D, Lie BA, Mclaren P, Vyse TJ, Wijmenga C, Allanore Y, Koeleman BPC; Spanish CGA Group; UKGCA Consortium; Vasculitis Clinical Research Consortium, Barrett JH, Cid MC, Salvarani C, Merkel PA, Morgan AW, González-Gay MA, Martín J.

Am J Hum Genet. 2017 Jan 5;100(1):64-74. doi: 10.1016/j.ajhg.2016.11.013. Epub 2016 Dec 29.

2.

A large-scale genetic analysis reveals a strong contribution of the HLA class II region to giant cell arteritis susceptibility.

Carmona FD, Mackie SL, Martín JE, Taylor JC, Vaglio A, Eyre S, Bossini-Castillo L, Castañeda S, Cid MC, Hernández-Rodríguez J, Prieto-González S, Solans R, Ramentol-Sintas M, González-Escribano MF, Ortiz-Fernández L, Morado IC, Narváez J, Miranda-Filloy JA; Spanish GCA Group, Beretta L, Lunardi C, Cimmino MA, Gianfreda D, Santilli D, Ramirez GA, Soriano A, Muratore F, Pazzola G, Addimanda O, Wijmenga C, Witte T, Schirmer JH, Moosig F, Schönau V, Franke A, Palm Ø, Molberg Ø, Diamantopoulos AP, Carette S, Cuthbertson D, Forbess LJ, Hoffman GS, Khalidi NA, Koening CL, Langford CA, McAlear CA, Moreland L, Monach PA, Pagnoux C, Seo P, Spiera R, Sreih AG, Warrington KJ, Ytterberg SR, Gregersen PK, Pease CT, Gough A, Green M, Hordon L, Jarrett S, Watts R, Levy S, Patel Y, Kamath S, Dasgupta B, Worthington J, Koeleman BP, de Bakker PI, Barrett JH, Salvarani C, Merkel PA, González-Gay MA, Morgan AW, Martín J.

Am J Hum Genet. 2015 Apr 2;96(4):565-80. doi: 10.1016/j.ajhg.2015.02.009. Epub 2015 Mar 26.

3.

Influence of the IL17A locus in giant cell arteritis susceptibility.

Márquez A, Hernández-Rodríguez J, Cid MC, Solans R, Castañeda S, Fernández-Contreras ME, Ramentol M, Morado IC, Narváez J, Gómez-Vaquero C, Martínez-Taboada VM, Ortego-Centeno N, Sopeña B, Monfort J, García-Villanueva MJ, Caminal-Montero L, de Miguel E, Blanco R; Spanish GCA Consortium, Palm O, Molberg O, Latus J, Braun N, Moosig F, Witte T, Beretta L, Santaniello A, Pazzola G, Boiardi L, Salvarani C, González-Gay MA, Martín J.

Ann Rheum Dis. 2014 Sep;73(9):1742-5. doi: 10.1136/annrheumdis-2014-205261. Epub 2014 Jun 11.

4.

Analysis of two autoimmunity genes, IRAK1 and MECP2, in giant cell arteritis.

Márquez A, Solans R, Hernández-Rodríguez J, Cid MC, Castañeda S, Ramentol M, Morado IC, Rodriguez-Rodriguez L, Narváez J, Gómez-Vaquero C, Miranda-Filloy JA, Martínez-Taboada VM, Ríos R, Sopeña B, Monfort J, García-Villanueva MJ, Martínez-Zapico A, Marí-Alfonso B, Sánchez-Martín J, Unzurrunzaga A, Raya E, de Miguel E, Hidalgo-Conde A, Blanco R, González-Gay MÁ, Martín J; Spanish GCA Consortium.

Clin Exp Rheumatol. 2014 May-Jun;32(3 Suppl 82):S30-3. Epub 2014 Apr 7.

PMID:
24709033
5.

Identification of the PTPN22 functional variant R620W as susceptibility genetic factor for giant cell arteritis.

Serrano A, Márquez A, Mackie SL, Carmona FD, Solans R, Miranda-Filloy JA, Hernández-Rodríguez J, Cid MC, Castañeda S, Morado IC, Narváez J, Blanco R, Sopeña B, García-Villanueva MJ, Monfort J, Ortego-Centeno N, Unzurrunzaga A, Marí-Alfonso B, Sánchez Martín J, de Miguel E, Magro C, Raya E; UK GCA Consortium; Spanish GCA Consortium, Braun N, Latus J, Molberg O, Lie BA, Moosig F, Witte T, Morgan AW, González-Gay MA, Martín J.

Ann Rheum Dis. 2013 Nov;72(11):1882-1886. doi: 10.1136/annrheumdis-2013-203641. Epub 2013 Aug 14.

6.

A case-control study suggests that the CCR6 locus is not involved in the susceptibility to giant cell arteritis.

Serrano A, Carmona FD, Castañeda S, Miranda-Filloy JA, Morado IC, Gomez-Vaquero C, Solans R, Sopeña B, Blanco R, Unzurrunzaga A, Ortego-Centeno N, Marí-Alfonso B, Hidalgo-Conde A, Hernández-Rodríguez J, Cid MC, Martín J, Gonzalez-Gay MA.

Clin Exp Rheumatol. 2013 Jan-Feb;31(1 Suppl 75):S5-8. Epub 2013 Jan 7.

PMID:
23306142
7.

Evidence of association of the NLRP1 gene with giant cell arteritis.

Serrano A, Carmona FD, Castañeda S, Solans R, Hernández-Rodríguez J, Cid MC, Prieto-González S, Miranda-Filloy JA, Rodríguez-Rodríguez L, Morado IC, Gomez-Vaquero C, Blanco R, Sopeña B, Ortego-Centeno N, Unzurrunzaga A, Marí-Alfonso B, Sánchez-Martín J, García-Villanueva MJ, Hidalgo-Conde A, Pazzola G, Boiardi L, Salvarani C, González-Gay MA, Martín J.

Ann Rheum Dis. 2013 Apr;72(4):628-30. doi: 10.1136/annrheumdis-2012-202609. Epub 2012 Dec 19. No abstract available.

8.

Autoimmune disease-associated CD226 gene variants are not involved in giant cell arteritis susceptibility in the Spanish population.

Serrano A, Carmona FD, Miranda-Filloy JA, Castañeda S, Rodríguez-Rodríguez L, Morado IC, Gómez-Vaquero C, Solans R, Sopeña B, Blanco R, Unzurrunzaga A, Ortego-Centeno N, Marí-Alfonso B, de Miguel E, Hidalgo-Conde A, Martín J, González-Gay MA.

Clin Exp Rheumatol. 2012 Jan-Feb;30(1 Suppl 70):S29-33. Epub 2012 May 10.

PMID:
22512842
9.

A nonsynonymous functional variant of the ITGAM gene is not involved in biopsy-proven giant cell arteritis.

Carmona FD, Serrano A, Rodríguez-Rodríguez L, Castañeda S, Miranda-Filloy JA, Morado IC, Narváez J, Solans R, Sopeña B, Marí-Alfonso B, Unzurrunzaga A, Ortego-Centeno N, Blanco R, de Miguel E, Hidalgo-Conde A, Martín J, González-Gay MA.

J Rheumatol. 2011 Dec;38(12):2598-601. doi: 10.3899/jrheum.110685. Epub 2011 Oct 1.

PMID:
21965647
10.

Role of the CCR5/Δ32CCR5 polymorphism in biopsy-proven giant cell arteritis.

Carmona FD, Rodríguez-Rodríguez L, Castañeda S, Miranda-Filloy JA, Morado IC, Narváez J, Marí-Alfonso B, Unzurrunzaga A, Ríos-Fernández R, Blanco R, de Miguel E, Martín J, González-Gay MA.

Hum Immunol. 2011 May;72(5):458-61. doi: 10.1016/j.humimm.2011.02.009. Epub 2011 Feb 25.

PMID:
21354457
11.

Role of rs1343151 IL23R and rs3790567 IL12RB2 polymorphisms in biopsy-proven giant cell arteritis.

Rodríguez-Rodríguez L, Carmona FD, Castañeda S, Miranda-Filloy JA, Morado IC, Narváez J, Marí-Alfonso B, Gómez-Vaquero C, Amigo-Díaz E, Ríos-Fernández R, Blanco R, Llorca J, Fernández-Gutiérrez B, Martín J, González-Gay MA.

J Rheumatol. 2011 May;38(5):889-92. doi: 10.3899/jrheum.101046. Epub 2011 Feb 1.

PMID:
21285166
12.

Role of the rs6822844 gene polymorphism at the IL2-IL21 region in biopsy-proven giant cell arteritis.

Rodríguez-Rodríguez L, Castañeda S, Vázquez-Rodríguez TR, Morado IC, Gómez-Vaquero C, Marí-Alfonso B, Miranda-Filloy JA, Narvaez J, Ortego-Centeno N, Vicente EF, Blanco R, Amigo-Diaz E, Fernández-Gutiérrez B, Martin J, González-Gay MA.

Clin Exp Rheumatol. 2011 Jan-Feb;29(1 Suppl 64):S12-6. Epub 2011 May 11.

PMID:
21269573
13.

Influence of IL2RA rs2104286 polymorphism in the risk of biopsy-proven giant cell arteritis.

Rodríguez-Rodríguez L, Castañeda S, Vázquez-Rodríguez TR, Morado IC, Marí-Alfonso B, Gómez-Vaquero C, Miranda-Filloy JA, Ortego-Centeno N, Narvaez J, Blanco R, Fernández-Gutiérrez B, Martín J, González-Gay MA.

J Rheumatol. 2010 Nov;37(11):2331-3. doi: 10.3899/jrheum.100388. Epub 2010 Sep 1.

PMID:
20810507
14.

Influence of CD40 rs1883832 polymorphism in susceptibility to and clinical manifestations of biopsy-proven giant cell arteritis.

Rodríguez-Rodríguez L, Castañeda S, Vázquez-Rodríguez TR, Morado IC, Marí-Alfonso B, Gómez-Vaquero C, Miranda-Filloy JA, Narvaez J, Ortego-Centeno N, Blanco R, Fernández-Gutiérrez B, Martín J, González-Gay MA.

J Rheumatol. 2010 Oct;37(10):2076-80. doi: 10.3899/jrheum.100362. Epub 2010 Aug 3.

PMID:
20682661
15.

Lack of association between hypoxia inducible factor-1 alpha gene polymorphisms and biopsy-proven giant cell arteritis.

Torres O, Palomino-Morales R, Vazquez-Rodriguez TR, Gamallo C, Morado IC, Miranda-Filloy JA, Amigo-Diaz E, Callejas-Rubio JL, Fernadez-Gutierrez B, Castañeda S, Morado IC, Martin J, Gonzalez-Gay MA.

Clin Exp Rheumatol. 2010 Jan-Feb;28(1 Suppl 57):40-5.

PMID:
20412701
16.

Lack of association between IFNGR1 gene polymorphisms and biopsy-proven giant cell arteritis.

Torres O, Palomino-Morales R, Vazquez-Rodriguez T, Castañeda S, Morado IC, Miranda-Filloy JA, Amigo-Diaz E, Callejas-Rubio JL, Fernandez-Gutierrez B, Martin J, Gonzalez-Gay MA.

Clin Exp Rheumatol. 2010 Jan-Feb;28(1 Suppl 57):31-4.

PMID:
20412699
17.

Role of BANK1 gene polymorphisms in biopsy-proven giant cell arteritis.

Torres O, Palomino-Morales R, Castañeda S, Vazquez-Rodriguez TR, Morado IC, Miranda-Filloy JA, Amigo-Diaz E, Vicente EF, Ortego-Centeno N, Fernandez-Gutierrez B, Martin J, Gonzalez-Gay MA.

J Rheumatol. 2010 Jul;37(7):1502-4. doi: 10.3899/jrheum.100016. Epub 2010 May 15.

PMID:
20472928
18.

Association between IL-18 gene polymorphisms and biopsy-proven giant cell arteritis.

Palomino-Morales RJ, Vazquez-Rodriguez TR, Torres O, Morado IC, Castañeda S, Miranda-Filloy JA, Callejas-Rubio JL, Fernandez-Gutierrez B, Gonzalez-Gay MA, Martin J.

Arthritis Res Ther. 2010;12(2):R51. doi: 10.1186/ar2962. Epub 2010 Mar 23.

19.

Lack of association between the rs6920220 (G/A) polymorphism of the 6q23 region and biopsy-proven giant cell arteritis.

Palomino-Morales R, Torres O, Vazquez-Rodriguez TR, Castañeda S, Morado IC, Miranda-Filloy JA, Amigo-Diaz E, Callejas-Rubio JL, Fernandez-Gutierrez B, Martin J, Gonzalez-Gay MA.

J Rheumatol. 2010 May;37(5):1020-3. doi: 10.3899/jrheum.091142. Epub 2010 Mar 15.

PMID:
20231195
20.

Role of the C8orf13-BLK region in biopsy-proven giant cell arteritis.

Torres O, Palomino-Morales R, Vazquez-Rodriguez TR, Castañeda S, Morado IC, Miranda-Filloy JA, Ortego-Centeno N, Fernandez-Gutierrez B, Martin J, Gonzalez-Gay MA.

Hum Immunol. 2010 May;71(5):525-9. doi: 10.1016/j.humimm.2010.02.016. Epub 2010 Mar 7.

PMID:
20156505
21.

Lack of association between TRAF1/C5 gene polymorphisms and biopsy-proven giant cell arteritis.

Torres O, Palomino-Morales R, Vazquez-Rodriguez TR, Castañeda S, Morado IC, Miranda-Filloy JA, Ortego-Centeno N, Gonzalez-Alvaro I, Fernandez-Gutierrez B, Martin J, Gonzalez-Gay MA.

J Rheumatol. 2010 Jan;37(1):131-5. doi: 10.3899/jrheum.090646. Epub 2009 Nov 16.

PMID:
19918040
22.

Lack of association between IRF5 gene polymorphisms and biopsy-proven giant cell arteritis.

Torres O, Palomino-Morales R, Vazquez-Rodriguez TR, Castañeda S, Morado IC, Miranda-Filloy JA, Valero F, Callejas-Rubio JL, Fernandez-Gutierrez B, Martin J, Gonzalez-Gay MA.

J Rheumatol. 2010 Jan;37(1):136-40. doi: 10.3899/jrheum.090744. Epub 2009 Nov 16.

PMID:
19918036
23.

Association between toll-like receptor 4 gene polymorphism and biopsy-proven giant cell arteritis.

Palomino-Morales R, Torres O, Vazquez-Rodriguez TR, Morado IC, Castañeda S, Callejas-Rubio JL, Miranda-Filloy JA, Fernandez-Gutierrez B, Martin J, Gonzalez-Gay MA.

J Rheumatol. 2009 Jul;36(7):1501-6. doi: 10.3899/jrheum.081286. Epub 2009 Jun 16.

PMID:
19531762
24.

Lack of association between STAT4 gene polymorphism and biopsy-proven giant cell arteritis.

Palomino-Morales R, Vazquez-Rodriguez TR, Morado IC, Castañeda S, Ortego-Centeno N, Miranda-Filloy JA, Lamas JR, Martin J, Gonzalez-Gay MA.

J Rheumatol. 2009 May;36(5):1021-5. doi: 10.3899/jrheum.081060. Epub 2009 Mar 30.

PMID:
19332627
25.

[Incidence and characteristics of tuberculosis in patients with autoimmune rheumatic diseases].

Vadillo Font C, Hernández-García C, Pato E, Morado IC, Salido M, Júdez E, Macarrón P, Fernández-Gutiérrez B, Abásolo L, Jover JA.

Rev Clin Esp. 2003 Apr;203(4):178-82. Spanish.

PMID:
12681200
26.

Disparate results in studies of methotrexate plus corticosteroids in the treatment of giant cell arteritis: comment on the article by Hoffman et al.

Jover JA, Hernández-Garcia C, Morado IC, Vargas E, Bañares A, Fernandez-Gutierrez B.

Arthritis Rheum. 2003 Apr;48(4):1158-9. No abstract available.

27.

Combined treatment of giant-cell arteritis with methotrexate and prednisone. a randomized, double-blind, placebo-controlled trial.

Jover JA, Hernández-García C, Morado IC, Vargas E, Bañares A, Fernández-Gutiérrez B.

Ann Intern Med. 2001 Jan 16;134(2):106-14.

PMID:
11177313
28.

Lag time between onset of symptoms and access to rheumatology care and DMARD therapy in a cohort of patients with rheumatoid arthritis.

Hernández-García C, Vargas E, Abásolo L, Lajas C, Bellajdell B, Morado IC, Macarrón P, Pato E, Fernández-Gutiérrez B, Bañares A, Jover JA.

J Rheumatol. 2000 Oct;27(10):2323-8.

PMID:
11036824
29.

The CD69 activation pathway in rheumatoid arthritis synovial fluid T cells.

Hernández-García C, Fernández-Gutiérrez B, Morado IC, Bañares AA, Jover JA.

Arthritis Rheum. 1996 Aug;39(8):1277-86.

PMID:
8702434

Supplemental Content

Loading ...
Support Center